Suppression of intestinal dysfunction in a Drosophila model of Parkinson’s disease is neuroprotective

被引:0
|
作者
Giorgio Fedele
Samantha H. Y. Loh
Ivana Celardo
Nuno Santos Leal
Susann Lehmann
Ana C. Costa
L. Miguel Martins
机构
[1] University of Cambridge,MRC Toxicology Unit
来源
Nature Aging | 2022年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The innate immune response mounts a defense against foreign invaders and declines with age. An inappropriate induction of this response can cause diseases. Previous studies showed that mitochondria can be repurposed to promote inflammatory signaling. Damaged mitochondria can also trigger inflammation and promote diseases. Mutations in pink1, a gene required for mitochondrial health, cause Parkinson’s disease, and Drosophila melanogaster pink1 mutants accumulate damaged mitochondria. Here, we show that defective mitochondria in pink1 mutants activate Relish targets and demonstrate that inflammatory signaling causes age-dependent intestinal dysfunction in pink1-mutant flies. These effects result in the death of intestinal cells, metabolic reprogramming and neurotoxicity. We found that Relish signaling is activated downstream of a pathway stimulated by cytosolic DNA. Suppression of Relish in the intestinal midgut of pink1-mutant flies restores mitochondrial function and is neuroprotective. We thus conclude that gut–brain communication modulates neurotoxicity in a fly model of Parkinson’s disease through a mechanism involving mitochondrial dysfunction.
引用
收藏
页码:317 / 331
页数:14
相关论文
共 50 条
  • [21] Neuroprotective effect of silymarin in a mouse model of Parkinson's disease
    de Jesus Perez-H, Jose
    Carrillo-Salgado, Carlos
    Garcia, Esperanza
    Ruiz-Mar, Gabriela
    Ramos, Espiridion
    Perez-Tamayo, Ruy
    Chavarria, Anahi
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 153 - 153
  • [22] Neuroprotective effects of Bacopa monnieri in Parkinson’s disease model
    Babita Singh
    Shivani Pandey
    Mohammad Rumman
    Abbas Ali Mahdi
    Metabolic Brain Disease, 2020, 35 : 517 - 525
  • [23] Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
    Esposito, Emanuela
    Impellizzeri, Daniela
    Mazzon, Emanuela
    Paterniti, Irene
    Cuzzocrea, Salvatore
    PLOS ONE, 2012, 7 (08):
  • [24] Neuroprotective mechanisms of cystamine in a murine model of Parkinson's disease
    Gibrat, C.
    Bousquet, M.
    Saint-Pierre, M.
    Levesque, D.
    Calon, F.
    Rouillard, C.
    Cicchetti, F.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S124 - S125
  • [25] A neuroprotective role for cerebrolysin in a rotenone model of Parkinson's disease
    Stoica, R.
    Popescu, B. O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S137 - S138
  • [26] Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
    Barneoud, P
    Mazadier, M
    Miquet, JM
    Parmentier, S
    Dubedat, P
    Doble, A
    Boireau, A
    NEUROSCIENCE, 1996, 74 (04) : 971 - 983
  • [27] Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease
    Blandini, F
    Armentero, MT
    Fancellu, R
    Blaugrund, E
    Nappi, G
    EXPERIMENTAL NEUROLOGY, 2004, 187 (02) : 455 - 459
  • [28] Neuroprotective effect of silymarin in a mouse model of Parkinson's disease
    Chavarria, A.
    Perez-H, J.
    Garcia, E.
    Carrillo-Salgado, C.
    Ruiz-Mar, G.
    Perez-Tamayo, R.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 194 - 194
  • [29] Neuroprotective effects of Bacopa monnieri in Parkinson's disease model
    Singh, Babita
    Pandey, Shivani
    Rumman, Mohammad
    Mahdi, Abbas Ali
    METABOLIC BRAIN DISEASE, 2020, 35 (03) : 517 - 525
  • [30] Protein expression in a Drosophila model of Parkinson's disease
    Xun, Zhiyin
    Sowell, Rena A.
    Kaufman, Thomas C.
    Clemmer, David E.
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (01) : 348 - 357